MENU

FBRX Forte Biosciences Inc Forecast, Technical & Fundamental Analysis

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications... Show more

FBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
FBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3060 Pegasus Park Drive
Phone
+1 310 618-6994
Employees
19
Web
https://www.fortebiorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME19.891.00
+5.29%
GameStop Corp
TSLA367.81-0.35
-0.10%
Tesla
BTC.X78259.520000-179.054690
-0.23%
Bitcoin cryptocurrency
AAPL315.34-0.88
-0.28%
Apple
SPY762.40-3.56
-0.46%
State Street® SPDR® S&P 500® ETF
Forte Biosciences (FBRX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com